only up 12ish so far in CanadaNeovasc Gains As Much As 30% In US Pre-Market Trade As Wins German Court Appeal 21 Mar 2019 09:12 ET 09:12 AM EDT, 03/21/2019 (MT Newswires) -- Neovasc (NVCN.TO), a healthcare technology company, said Thursday that the Higher Regional Court in Munich has fully dismissed the case on appeal by the company. Shares at last look rose 14.9% on US trade, and may gain more in Toronto trade, where its shares were up 1.6% to $0.62 apiece on Wednesday. According to a statement, Edwards Lifesciences CardiAQ LLC brought the case against Neovasc in Germany, over claims of full ownership rights to one of Neovasc's European patent applications for its Tiara. Both parties had appealed a June 2017 decision, in which Munich had awarded co-ownership rights to CardiAQ. "CardiAQ withdrew its appeal for full ownership during the course of the appeal. In dismissing the remainder of CardiAQ's case, the German court now found that CardiAQ had not contributed to the invention of the Tiara and found Neovasc to be the rightful inventor and owner of all rights to the disputed Tiara European patent application," according to a statement. Price: 0.6200, Change: +0.0100, Percent Change: +1.64